THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
162,504,460
Share change
-81,095
Total reported value
$791,412,125
Put/Call ratio
213%
Price per share
$4.87
Number of holders
139
Value change
-$4,590,259
Number of buys
72
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2018

As of 31 Mar 2018, THERAPEUTICSMD INC - COM (TXMD) was held by 139 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 162,504,460 shares. The largest 10 holders included Bank of New York Mellon Corp, JPMORGAN CHASE & CO, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, STATE STREET CORP, Voya Investment Management LLC, and CITADEL ADVISORS LLC. This page lists 139 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.